Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
McKinsey
Fish and Richardson
Covington
Daiichi Sankyo
Cantor Fitzgerald
Cipla
Queensland Health
US Department of Justice
Teva

Generated: January 18, 2018

DrugPatentWatch Database Preview

MIXTARD HUMAN 70/30 Drug Profile

« Back to Dashboard

Which patents cover Mixtard Human 70/30, and when can generic versions of Mixtard Human 70/30 launch?

Mixtard Human 70/30 is a drug marketed by Bayer Pharms and is included in one NDA.

The generic ingredient in MIXTARD HUMAN 70/30 is insulin recombinant purified human; insulin susp isophane semisynthetic purified human. There are thirty-nine drug master file entries for this compound. Additional details are available on the insulin recombinant purified human; insulin susp isophane semisynthetic purified human profile page.
Summary for MIXTARD HUMAN 70/30
Drug patent expirations by year for MIXTARD HUMAN 70/30

US Patents and Regulatory Information for MIXTARD HUMAN 70/30

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms MIXTARD HUMAN 70/30 insulin recombinant purified human; insulin susp isophane semisynthetic purified human INJECTABLE;INJECTION 019585-001 Mar 11, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Covington
Federal Trade Commission
Mallinckrodt
Cerilliant
AstraZeneca
McKinsey
McKesson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot